Excision BioTherapeutics is a private company focused on developing advanced gene-editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections. They develop gene-editing medicines that eradicate or disrupt viral genes in human patients. Their mission is to advance gene-editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.

San Francisco, CA, USA

Philadelphia, PA, USA

Excision BioTherapeutics

Anzu Partners is an investment firm in Washington DC.

Open roles with our Portfolio Companies